|
|
|
|
|
|
|
Reata Pharmaceuticals Inc. (RETA)
|
|
60.14 -1.3 (-2.12%)
|
11-14 16:00
|
|
Open:
|
62.1
|
Pre. Close:
|
61.44
|
|
High:
|
64.12
|
Low:
|
58.98
|
|
Volume:
|
170,219
|
Market Cap:
|
1787M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
64.539 - 65.158
|
65.158 - 65.533
|
|
Low:
|
57.734 - 58.5
|
58.5 - 58.964
|
|
Close:
|
59.254 - 60.512
|
60.512 - 61.272
|
|
|
|
Technical analysis (as of: 2018-11-14 4:37:33 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 76.70 One year: 85.46
|
|
Support:
|
Support1: 53.52 Support2: 44.53
|
|
Resistance:
|
Resistance1:
65.66 Resistance2: 73.17
|
|
Pivot:
|
61.93 
|
|
Moving Averages:
|
MA(5): 64.08  MA(20): 61.21
MA(100): 66.68 MA(250): 43.13
|
|
MACD:
|
MACD(12,26):
-1.26 Signal(12,26,9): -1.97
|
|
%K %D:
|
%K(14,3): 40.47 %D(3): 51.80
|
|
RSI:
|
RSI(14): 43.03
|
|
52-Week:
|
High: 99.5
Low: 19.31 Change(%): 151.5
|
|
Average Vol(K):
|
3-Month: 28891
10-Days 21483
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.RETA has closed above bottom band by 40.0%. Bollinger Bands are 19.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-11-07T14:22:04-05:00
Reata Pharmaceuticals, Inc. (RETA) CEO Warren Huff on Q3 2018 Results - Earnings Call Transcript
2018-11-07T07:08:02-05:00
Reata Pharmaceuticals misses by $0.28, misses on revenue
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
